AI-generated summary
The authors pooled 12 randomized controlled trials with 322 subjects to compare 1064 nm Q-switched Nd:YAG laser combined with another treatment against the laser alone for refractory melasma. They report a greater reduction in MASI/mMASI scores with combined treatment, with a small pooled effect size, and more mild, self-resolving burning, stinging and erythema.
- Participants
- 322
- Studies included
- 12
- Who or what was studied
- Subjects with refractory melasma in randomized controlled trials
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract reports a small pooled effect size, moderate heterogeneity in some outcomes, and evidence of possible publication bias was assessed but its results are not described.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Meta-analysis, Control group, Publication bias, Primary outcome, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.